What is Laboratorio Farmaceutico Erfo SpA PB Ratio?
Laboratorio Farmaceutico Erfo SpAMIL:ERFO -2.54%68 PB Ratio is 1.23 as of Jul. 02, 2026, which is 20% below its 10-year median of 1.54. GuruFocus rates MIL:ERFO with a GF Score™ of 68/100 and a GF Value™ of €2.10 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,893 Consumer Packaged Goods companies, Laboratorio Farmaceutico Erfo SpA ranks better than 53.41% on this metric.
MIL:ERFO'
s PB Ratio Range Over the Past 10 Years
Min: 0.98 Med: 1.54 Max: 5.9
Current: 1.22
During the past 7 years, Laboratorio Farmaceutico Erfo SpA's highest PB Ratio was 5.90. The lowest was 0.98. And the median was 1.54.
MIL:ERFO's PB Ratio is ranked better than 53.41% of 1893
companies
in the Consumer Packaged Goods industry
Industry Median: 1.34
vs MIL:ERFO: 1.22
During the past 12 months, Laboratorio Farmaceutico Erfo SpA's average Book Value Per Share Growth Rate was 4.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 34.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.30% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Laboratorio Farmaceutico Erfo SpA was 34.40% per year. The lowest was 12.80% per year. And the median was 16.20% per year.
Back to Basics: PB Ratio
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Laboratorio Farmaceutico Erfo SpA PB Ratio Related Terms
Laboratorio Farmaceutico Erfo SpA PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorio Farmaceutico Erfo SpA PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's PB Ratio falls into.
Laboratorio Farmaceutico Erfo SpA PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a PB Ratio of 1.23 as of Jul. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. This is 20% below median its historical median of 1.54. Over the past decade, Laboratorio Farmaceutico Erfo SpA's PB Ratio has ranged from 0.98 to 5.90. According to the industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #882 out of 1893 companies in the Consumer Packaged Goods industry, placing it in the top 46.6%.
Is Laboratorio Farmaceutico Erfo SpA's PB Ratio too high?
Laboratorio Farmaceutico Erfo SpA's current PB Ratio of 1.23 is 20% below median its 10-year median of 1.54. Over the past 10 years, this metric has ranged from a low of 0.98 to a high of 5.90. The Consumer Packaged Goods industry median PB Ratio is 1.34. Laboratorio Farmaceutico Erfo SpA's value of 1.23 is 8.2% below this industry median. Based on the distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #882 out of 1893 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Farmaceutico Erfo SpA's PB Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Laboratorio Farmaceutico Erfo SpA ranks #882 out of 1893 companies for PB Ratio. This puts Laboratorio Farmaceutico Erfo SpA in the upper half of its industry. The industry median PB Ratio is 1.34. Laboratorio Farmaceutico Erfo SpA's value of 1.23 is 8.2% below this benchmark. Historically, Laboratorio Farmaceutico Erfo SpA's own PB Ratio has ranged from 0.98 to 5.90 over the past decade. While the company's 10-year median is 1.54 vs. the industry median of 1.34, Laboratorio Farmaceutico Erfo SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.34, based on 1,893 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current PB Ratio of 1.23 is 8.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Laboratorio Farmaceutico Erfo SpA and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current PB Ratio is 1.23, which is 20% below median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.10, compared to a current price of €1.15 — trading 45.2% below its estimated fair value. The current PB Ratio is 1.23, which is 20% below median its 10-year median of 1.54 and 8.2% below the Consumer Packaged Goods industry median of 1.34. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current PB Ratio is 1.23 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued.
The current stock price of €1.15 is trading 45.2% below its estimated GF Value™ of €2.10.
GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.
Key valuation signals for MIL:ERFO:
PB Ratio: 1.23 (20% below median its 10-year median of 1.54)
GF Value™: €2.10 vs. price of €1.15 (45.2% below fair value)
Industry Position: 8.2% below the Consumer Packaged Goods median (#882 of 1893)
No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorio Farmaceutico Erfo SpA Business Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
68GF Score
Get the complete analysis for MIL:ERFO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:ERFO has been successfully added to your 
